Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Gynecology

Free Subscription 25.03.2019 3 Acta Obstet Gynecol Scand 4 Am J Obstet Gynecol 1 Ann Oncol 3 Aust N Z J Obstet Gynaecol 2 BMC Cancer 2 BMJ 2 Br J Cancer 5 Cancer Res 9 Eur J Obstet Gynecol Reprod Biol 9 Fertil Steril 2 Gynecol Endocrinol 4 Gynecol Oncol 3 Int J Cancer 1 Int J Oncol 1 Int J Radiat Oncol Biol Phys 5 J Clin Endocrinol Metab 3 J Urol 2 Lancet Glob Health 1 Lancet HIV 2 Lancet Oncol 1 Lancet Public Health 1 Obstet Gynecol 3 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Obstet Gynecol Scand

1. BORSETH KF, Acharya G, Kiserud T, Trovik J, et al
   Incidence of gynecological fistula and its surgical treatment: a national registry-based study.
   Acta Obstet Gynecol Scand. 2019 Mar 19. doi: 10.1111/aogs.13611.
   PubMed     Text format     Abstract available
   
   
2. SAAVALAINEN L, Lassus H, But A, Tiitinen A, et al
   A cohort study of 49 933 women with surgically verified endometriosis - increased incidence of breast cancer below the age of 40.
   Acta Obstet Gynecol Scand. 2019 Mar 18. doi: 10.1111/aogs.13609.
   PubMed     Text format     Abstract available
   
   
3. DOLMANS MM, Cacciottola L, Amorim C, Manavella D, et al
   Translational research aiming to improve survival of ovarian tissue transplants using adipose tissue-derived stem cells.
   Acta Obstet Gynecol Scand. 2019 Mar 19. doi: 10.1111/aogs.13610.
   PubMed     Text format     Abstract available
   
   

   
   Am J Obstet Gynecol

4. OKESENE-GAFA KAM, Li M, Mckinlay CJD, Taylor RS, et al
   Effect of antenatal dietary interventions in maternal obesity on pregnancy weight-gain and birthweight: Healthy Mums and Babies (HUMBA) randomized trial.
   Am J Obstet Gynecol. 2019 Mar 13. pii: S0002-9378(19)30478.
   PubMed     Text format     Abstract available
   
   
5. GOODNIGHT WH, Bahtiyar O, Bennett KA, Emery SP, et al
   Subsequent Pregnancy Outcomes After Open Maternal-Fetal Surgery for Myelomeningocele.
   Am J Obstet Gynecol. 2019 Mar 15. pii: S0002-9378(19)30483.
   PubMed     Text format     Abstract available
   
   
6. ODUYEBO T, Zapata LB, Boutot ME, Tepper NK, et al
   Factors Associated with Postpartum Use of Long-Acting Reversible Contraception.
   Am J Obstet Gynecol. 2019 Mar 15. pii: S0002-9378(19)30480.
   PubMed     Text format     Abstract available
   
   
7. SCHOEP ME, Nieboer TE, van der Zanden M, Braat DDM, et al
   The impact of menstrual symptoms on everyday life: a survey among 42,879 women.
   Am J Obstet Gynecol. 2019 Mar 2. pii: S0002-9378(19)30427.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

8. BUECHEL M, Herzog TJ, Westin SN, Coleman RL, et al
   Treatment of Patients with Recurrent Epithelial Ovarian Cancer for Whom Platinum is Still an Option.
   Ann Oncol. 2019 Mar 18. pii: 5384492. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Aust N Z J Obstet Gynaecol

9. MACDONALD EJ, Lepine S, Pledger M, Geller SE, et al
   Pre-eclampsia causing severe maternal morbidity - A national retrospective review of preventability and opportunities for improved care.
   Aust N Z J Obstet Gynaecol. 2019 Mar 18. doi: 10.1111/ajo.12971.
   PubMed     Text format     Abstract available
   
   
10. BURLING MJ, Gamet K, Eva L, Tan AL, et al
    Referral patterns for genetic counselling of women diagnosed with tubo-ovarian or peritoneal high-grade serous carcinoma (HGSC) within the Auckland Gynaecological Oncology Centre.
    Aust N Z J Obstet Gynaecol. 2019 Mar 18. doi: 10.1111/ajo.12964.
    PubMed     Text format     Abstract available
    
    
11. CASEY JRR, Banks J, Braniff K, Buettner P, et al
    The effects of expressing antenatal colostrum in women with diabetes in pregnancy: A retrospective cohort study.
    Aust N Z J Obstet Gynaecol. 2019 Mar 19. doi: 10.1111/ajo.12966.
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

12. BU Q, Wang S, Ma J, Zhou X, et al
    The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.
    BMC Cancer. 2018;18:1182.
    PubMed     Text format     Abstract available
    
    
13. ABDULRASHID K, AlHussaini N, Ahmed W, Thalib L, et al
    Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis.
    BMC Cancer. 2019;19:256.
    PubMed     Text format     Abstract available
    
    

    
    BMJ

14. HUGHES G, Saunders J
    Mycoplasma genitalium: the next sexually transmitted superbug?
    BMJ. 2018;363:k4376.
    PubMed     Text format    
    
    
15. MAGNUS MC, Wilcox AJ, Morken NH, Weinberg CR, et al
    Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study.
    BMJ. 2019;364:l869.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

16. FORTNER RT, Terry KL, Bender N, Brenner N, et al
    Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.
    Br J Cancer. 2019 Mar 21. pii: 10.1038/s41416-019-0422.
    PubMed     Text format     Abstract available
    
    
17. WESTERGAARD MCW, Andersen R, Chong C, Kjeldsen JW, et al
    Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer.
    Br J Cancer. 2019 Mar 19. pii: 10.1038/s41416-019-0425.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

18. SAINI U, Suarez AA, Naidu S, Wallbillich JJ, et al
    STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube.
    Cancer Res. 2018;78:1739-1750.
    PubMed     Text format     Abstract available
    
    
19. SHARMA SK, Chow A, Monette S, Vivier D, et al
    Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models.
    Cancer Res. 2018;78:1820-1832.
    PubMed     Text format     Abstract available
    
    
20. PRICE C, Gill S, Ho ZV, Davidson SM, et al
    Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers.
    Cancer Res. 2019 Mar 21. pii: 0008-5472.CAN-18-2674.
    PubMed     Text format     Abstract available
    
    
21. SRIVASTAVA AK, Banerjee A, Cui T, Han C, et al
    Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer.
    Cancer Res. 2019 Mar 20. pii: 0008-5472.CAN-18-3668.
    PubMed     Text format     Abstract available
    
    
22. CASTLE PE
    Charting the Future of Cancer Health Disparities Research-Letter.
    Cancer Res. 2018;78:1883-1885.
    PubMed     Text format    
    
    

    
    Eur J Obstet Gynecol Reprod Biol

23. OUDMAN E, Wijnia JW, Oey M, van Dam M, et al
    Wernicke's encephalopathy in hyperemesis gravidarum: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:84-93.
    PubMed     Text format     Abstract available
    
    
24. MEZQUITA G, Muruzabal JC, Perez B, Aguirre S, et al
    Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:79-83.
    PubMed     Text format     Abstract available
    
    
25. SEO JW, Lee DY, Kim SE, Yoon BK, et al
    Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:53-57.
    PubMed     Text format     Abstract available
    
    
26. FISCHETTI A, Rutigliani M, Romano N, Marinaro EL, et al
    Imaging findings of ovarian leiomyosarcoma with histopathologic correlations.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 12. pii: S0301-2115(19)30116.
    PubMed     Text format     Abstract available
    
    
27. ZHUANG X, Lv ZC, Shi J, Lin JH, et al
    A clinical study on the difference among proteinuria components in preeclampsia and pregnancies complicated with chronic nephrosis.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:105-108.
    PubMed     Text format     Abstract available
    
    
28. DI TOMMASO M, Carotenuto B, Seravalli V, Magro Malosso ER, et al
    Evaluation of umbilical cord pulsatility after vaginal delivery in singleton pregnancies at term.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:94-97.
    PubMed     Text format     Abstract available
    
    
29. ZULFEEN M, Tatapudi R, Sowjanya R
    IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:46-52.
    PubMed     Text format     Abstract available
    
    
30. MITTAL P, Suri J, Pruthi N, Pandey D, et al
    Comparison of placenta accreta spectrum disorders diagnosed in intrapartum and antepartum period- A three year experience in a tertiary referral unit of India.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:41-45.
    PubMed     Text format     Abstract available
    
    
31. KHALIFEH A, Berghella A, Moreno S, Corelli K, et al
    Stroke recurrence in pregnancy: Experience at a regional referral center.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:75-78.
    PubMed     Text format     Abstract available
    
    

    
    Fertil Steril

32. 
    Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion.
    Fertil Steril. 2018;110:1022-1028.
    PubMed     Text format     Abstract available
    
    
33. MARCELLIN L, Santulli P, Bourdon M, Comte C, et al
    Serum antimullerian hormone concentration increases with ovarian endometrioma size.
    Fertil Steril. 2019 Mar 13. pii: S0015-0282(19)30051.
    PubMed     Text format     Abstract available
    
    
34. JUNEAU CR, Franasiak JM, Goodman LR, Marin D, et al
    Celiac disease is not more prevalent in patients undergoing in vitro fertilization and does not affect reproductive outcomes with or without treatment: a large prospective cohort study.
    Fertil Steril. 2018;110:437-442.
    PubMed     Text format     Abstract available
    
    
35. 
    Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion.
    Fertil Steril. 2018;110:380-386.
    PubMed     Text format     Abstract available
    
    
36. KROON SJ, Ravel J, Huston WM
    Cervicovaginal microbiota, women's health, and reproductive outcomes.
    Fertil Steril. 2018;110:327-336.
    PubMed     Text format     Abstract available
    
    
37. CARPINELLO O, DeCherney A
    Facts often fail to overcome preconceived notions.
    Fertil Steril. 2018;110:1043-1044.
    PubMed     Text format     Abstract available
    
    
38. GINSBURG ES, Jellerette-Nolan T, Daftary G, Du Y, et al
    Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization.
    Fertil Steril. 2018;110:1101-1108.
    PubMed     Text format     Abstract available
    
    
39. LAZZERI L, Morosetti G, Centini G, Monti G, et al
    A sonographic classification of adenomyosis: interobserver reproducibility in the evaluation of type and degree of the myometrial involvement.
    Fertil Steril. 2018;110:1154-1161.
    PubMed     Text format     Abstract available
    
    
40. SAUER MV
    Revisiting the early days of oocyte and embryo donation: relevance to contemporary clinical practice.
    Fertil Steril. 2018;110:981-987.
    PubMed     Text format     Abstract available
    
    

    
    Gynecol Endocrinol

41. MENDOZA N, Diaz-Ropero MP, Aragon M, Maldonado V, et al
    Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
    Gynecol Endocrinol. 2019 Mar 16:1-6. doi: 10.1080/09513590.2019.1576620.
    PubMed     Text format     Abstract available
    
    
42. KAHRAMAN S, Eroglu Altinova A, Elgun S, Yalcin MM, et al
    Serum activities of dipeptidyl peptidase-4 and adenosine deaminase in polycystic ovary syndrome: association with obesity.
    Gynecol Endocrinol. 2019 Mar 21:1-5. doi: 10.1080/09513590.2019.1581165.
    PubMed     Text format     Abstract available
    
    

    
    Gynecol Oncol

43. LAWRENSON K, Song F, Hazelett DJ, Kar SP, et al
    Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
    Gynecol Oncol. 2019 Mar 19. pii: S0090-8258(19)30133.
    PubMed     Text format     Abstract available
    
    
44. LEITAO MM JR
    The change in landscape after a new landmark is constructed: Radical hysterectomy for early cervical cancer and Minimally Invasive Surgery.
    Gynecol Oncol. 2019;153:1-2.
    PubMed     Text format    
    
    
45. HUANG M, Kamath P, Schlumbrecht M, Miao F, et al
    Identifying disparities in germline and somatic testing for ovarian cancer.
    Gynecol Oncol. 2019 Mar 16. pii: S0090-8258(19)30155.
    PubMed     Text format     Abstract available
    
    
46. WATSON CH, Lopez-Acevedo M, Broadwater G, Kim AH, et al
    A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery.
    Gynecol Oncol. 2019 Mar 15. pii: S0090-8258(19)30131.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

47. BALLABIO S, Craparotta I, Paracchini L, Mannarino L, et al
    Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number variation in 3p26.2 and 8q24.3.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32288.
    PubMed     Text format     Abstract available
    
    
48. LI H, Zhang W, Niu C, Lin C, et al
    Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32293.
    PubMed     Text format     Abstract available
    
    
49. HALEC G, Scott ME, Farhat S, Darragh TM, et al
    Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
    Int J Cancer. 2018;143:2884-2891.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

50. HERNANDEZ-JUAREZ J, Vargas-Sierra O, Herrera LA, Cantu De Leon D, et al
    Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
    Int J Oncol. 2019 Mar 14. doi: 10.3892/ijo.2019.4749.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

51. CHINO J, Beriwal S
    Advanced Treatment Technique for Locally Advanced Cervical Cancer: Time for a Standard of Care Shift?
    Int J Radiat Oncol Biol Phys. 2019;103:1098-1099.
    PubMed     Text format    
    
    

    
    J Clin Endocrinol Metab

52. SOUTHMAYD EA, Williams NI, Mallinson RJ, De Souza MJ, et al
    Energy Deficiency Suppresses Bone Turnover in Exercising Women with Menstrual Disturbances.
    J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393293. doi: 10.1210/jc.2019-00089.
    PubMed     Text format     Abstract available
    
    
53. SIMON SL, McWhirter L, Behn CD, Bubar KM, et al
    Morning circadian misalignment is associated with insulin resistance in girls with obesity & Polycystic Ovarian Syndrome.
    J Clin Endocrinol Metab. 2019 Mar 19. pii: 5381916. doi: 10.1210/jc.2018-02385.
    PubMed     Text format     Abstract available
    
    
54. JIANG J, Cui J, Wang A, Mu Y, et al
    Association Between Age at Natural Menopause and Risk of Type 2 Diabetes in Postmenopausal Obese and Non-Obese Females.
    J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393286. doi: 10.1210/jc.2018-02310.
    PubMed     Text format     Abstract available
    
    
55. ZHAO Y, Wang L, Liu H, Cao Z, et al
    Particulate Air Pollution Exposure and Plasma Vitamin D Levels in Pregnant Women: A Longitudinal Cohort Study.
    J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393290. doi: 10.1210/jc.2018-02713.
    PubMed     Text format     Abstract available
    
    
56. BRISTOW SM, Horne AM, Gamble GD, Mihov B, et al
    Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women.
    J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393287. doi: 10.1210/jc.2019-00111.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

57. NIEDERBERGER C
    Re: Impact of Male Partner Characteristics and Semen Parameters on In Vitro Fertilization and Obstetric Outcomes in a Frozen Oocyte Donor Model.
    J Urol. 2019 Mar 19:10109701JU0000554796152869.
    PubMed     Text format    
    
    
58. NIEDERBERGER C
    Re: Single-Cell Analysis of [Ca2+]i Signalling in Sub-Fertile Men: .2+]i Signalling in Sub-Fertile Men: Characteristics and Relation to Fertilization Outcome.
    J Urol. 2019;201:428-429.
    PubMed     Text format    
    
    
59. KAPADIA AA, Hedges JC
    Editorial Comment.
    J Urol. 2018;200:422.
    PubMed     Text format    
    
    

    
    Lancet Glob Health

60. MCCLURE EM, Goldenberg RL
    Understanding causes of stillbirth: moving in the right direction.
    Lancet Glob Health. 2019;7:e400-e401.
    PubMed     Text format    
    
    
61. MADHI SA, Briner C, Maswime S, Mose S, et al
    Causes of stillbirths among women from South Africa: a prospective, observational study.
    Lancet Glob Health. 2019;7:e503-e512.
    PubMed     Text format     Abstract available
    
    

    
    Lancet HIV

62. CARVETH-JOHNSON T, Stingone C, Nwokolo N, Whitlock G, et al
    Doxycycline use in MSM taking PrEP.
    Lancet HIV. 2018;5:e482.
    PubMed     Text format    
    
    

    
    Lancet Oncol

63. KONSTANTINOPOULOS PA, Barry WT, Birrer M, Westin SN, et al
    Olaparib and alpha-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
    Lancet Oncol. 2019 Mar 14. pii: S1470-2045(18)30905.
    PubMed     Text format     Abstract available
    
    
64. LEDERMANN JA
    Extending the scope of PARP inhibitors in ovarian cancer.
    Lancet Oncol. 2019 Mar 14. pii: S1470-2045(19)30019.
    PubMed     Text format    
    
    

    
    Lancet Public Health

65. LEWIS J, White PJ
    Changes in chlamydia prevalence and duration of infection estimated from testing and diagnosis rates in England: a model-based analysis using surveillance data, 2000-15.
    Lancet Public Health. 2018 May 15. pii: S2468-2667(18)30071.
    PubMed     Text format     Abstract available
    
    

    
    Obstet Gynecol

66. 
    Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
    Obstet Gynecol. 2016;128:e111-e130.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

67. HSU HC, Tai YJ, Chen YL, Chiang YC, et al
    Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.
    PLoS One. 2018;13:e0204950.
    PubMed     Text format     Abstract available
    
    
68. WEN YF, Cheng TT, Chen XL, Huang WJ, et al
    Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy.
    PLoS One. 2018;13:e0204334.
    PubMed     Text format     Abstract available
    
    
69. COOPER S, Leon N, Namadingo H, Bobrow K, et al
    "My wife's mistrust. That's the saddest part of being a diabetic": A qualitative study of sexual well-being in men with Type 2 diabetes in sub-Saharan Africa.
    PLoS One. 2018;13:e0202413.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

70. GARTUNG A, Yang J, Sukhatme VP, Bielenberg DR, et al
    Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor.
    Proc Natl Acad Sci U S A. 2019 Jan 15. pii: 1803999116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: